Reach Us +44-7482-864460
Visualization And Data Mining Of Tremendous Cancer Transcriptome Data | 86551
ISSN: 1747-0862

Journal of Molecular and Genetic Medicine
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Share This Page

Visualization and data mining of tremendous cancer transcriptome data

Joint Event on 10th International Conference on Genomics and Molecular Biology & 6th International Conference on Integrative Biology

Zefang Tang

Peking University, China

Posters & Accepted Abstracts: J Mol Genet Med

DOI: 10.4172/1747-0862-C2-028

The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) projects produced RNA-Seq data for tens of thousands of cancer and non-cancer samples, providing an unprecedented opportunity for data mining, cancer drug target discovery and data visualization. In recent years, promising cancer drugs including panitumumab and bevacizumab have been developed that inhibit cancer cells by selectively targeting over-expressed EGFR or VEGF genes in cancer cells, while leaving normal cells unharmed. Genetic alterations will influence gene expression directly or indirectly. It is a frequently used strategy to discover candidate cancer drug targets through the finding of cancer specific expressed genes. This study aims to investigate normalization methods for integrating different expression datasets, explore effective approaches to obtain differentially expressed genes, profile the prognostic genes and transcripts in survival analyses, characterize the distribution of cancer specific genes or transcripts, and analyze their biological functions. Meanwhile, we will develop tools for visualizing integrated expression data, with the aim to disseminate such data to the wide research community. We also plan to find useful biomarkers for early diagnosis. Finally, by investigating the association between genetic alterations and over-expression, we aim to elucidate the underlying genetic mechanisms of differentially expressed genes. [email protected]